Paris (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Poster #P024 Patient preference data presented today at the 10th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) demonstrated the ...
Wevelgem, Belgium (ots/PRNewswire) - Jacoti Hearing Suite, an innovative set of hearing applications created by Jacoti bvba, has been named a Global Mobile Awards 2017 Nominee. Products entered in this prestigious program are judged by a preeminent panel of more than 250 independent judges from across the world, ...
Dublin (ots/PRNewswire) - -- Allergan enters skin quality category with new injectable product using VYCROSS® technology[1] for use on the face, neck, décolletage and hands[2] -- Hyaluronic Acid (HA) gel designed to improve skin's smoothness (absence of fine lines), hydration and elasticity for up to nine months ...
Calgary, Alberta (ots/PRNewswire) - Several Key Proteins That Drive Kidney (Renal) Disease and Dialysis Risk are Downregulated After a Single Dose of Apabetalone Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today announced preliminary results from the New Zealand based Phase 1 trial with severe kidney (renal) impaired patients. The data showed ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. based media - Merck is broadening its efforts to support ART clinics to achieve excellence for patients - Through leading edge education and training, the Centre of Excellence aims to support clinics to achieve consistent and high level of outcome Merck, a leading science and technology company, today announced the opening of its first Centre of Excellence (CoE) ...
International Union Against Cancer (UICC)
Davos, Switzerland (ots/PRNewswire) - - New city-level initiative launched in partnership between the Union for International Cancer Control (UICC), the World Economic Forum and World Bank - A commitment to saving lives by helping country and city leaders improve the health of their citizens and reduce inequities in access to quality cancer treatment and care - A ...
Dublin (ots/PRNewswire) - DS Biopharma (DS), a privately held, clinical stage, pharmaceutical drug discovery and development company, today announced that recruitment has begun in two separate Phase 2b atopic dermatitis (AD) studies with its lead compound DS107. An Oral DS107 Phase 2b study (called 'ADvance') in 300 ...
Tokyo and Haifa, Israel (ots/PRNewswire) - INSIGHTEC (http://www.insightec.com/JP/), the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its Exablate Neuro system for the non-invasive treatment of essential tremor in ...
Sunnyvale, California (ots/PRNewswire) - Practice-Changing Study Presented at the 2016 Best of ASTRO Meeting Accuray Incorporated (NASDAQ: ARAY) announced today new data showing that 80 percent of patients with solitary plasmacytoma of the bone (SPB) had excellent cancer control four years after receiving ...
Aachen / Pisa (ots) - Grünenthal receives Breakthrough Therapy Designation from U.S. FDA for neridronic acid for the treatment of complex regional pain syndrome (CRPS), a debilitating orphan disease with high medical need - Neridronic acid is the first investigational medicine to receive Breakthrough Therapy ...
London (ots/PRNewswire) - Global Kinetics Corporation (http://www.globalkineticscorporation.com/) and uMotif (https://www.umotif.com/) have announced a new partnership to offer a comprehensive, validated and simple to use data capture platform to advance the treatment and understanding of Parkinson's disease. Bringing together leading proprietary products, the Global ...
Rheinfelden, Switzerland (ots/PRNewswire) - Zeria Pharmaceutical Co., Ltd launched Zentacort® 3mg capsules (generic name: Budesonide) in Japan on November 29, 2016. Zentacort® is sold as Entocort(TM) in more than 40 countries and recommended as first line therapy for treatment in Crohn's Disease (CD) in various ...
Tokyo and Chertsey, England (ots/PRNewswire) - Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, "Astellas"), today announced that Astellas Pharma Europe Ltd., ("Astellas Pharma Europe") has entered into a definitive agreement with Grünenthal under which Astellas Pharma Europe will transfer the exclusive rights for Qutenza(TM) (capsaicin 8% patch) in Europe, Middle East and Africa to Grünenthal. (Logo: ...
Munich (ots/PRNewswire) - First patient enrolled in EMIT-AF/VTE study (NCT02950168), a European registry to assess edoxaban management in patients undergoing medical procedures[1] Daiichi Sankyo Europe GmbH (hereafter, Daiichi Sankyo) today announced that the first patient has been enrolled in the EMIT-AF/VTE ...
Sunnyvale, California (ots/PRNewswire) - European and U.S. Hospitals Advance Adaptive Cancer Care with Image-Guided Radiation Therapy System Accuray Incorporated (NASDAQ: ARAY) announced today that leading hospitals in Europe and the United States are now treating patients with the new Radixact(TM) Treatment Delivery System, fully integrated with the new Accuray ...
Uithoorn, The Netherlands (ots/PRNewswire) - Acquisition provides HOYA Vision Care access to an important new market HOYA Vision Care, a division of HOYA Group (HOYA) today announced a definitive agreement to acquire the safety prescription eyewear business of 3M. This safety prescription eyewear business is an ...
Lugano, Switzerland and San Diego (ots/PRNewswire) - Phase 2 study results presented at American Society of Hematology Annual Meeting on Saturday, December 3, 2016 Global Phase 3 study site recruitment is ongoing Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, ...
Bagsværd, Denmark (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Novo Nordisk today announced that NovoSeven® (rFVIIa), a portable room temperature stable recombinant activated factor VIIa, resolved 96.5% of bleeds when ...
Bagsværd, Denmark (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Novo Nordisk today announced new phase 3b trial (DUAL VII) results with Xultophy® (IDegLira). Xultophy® is a once-daily, single injection fixed combination ...
Vista, California (ots/PRNewswire) - * Aperio RNA ISH Algorithm and BOND RX are for Research Use Only. Not for use in diagnostic procedures. Leica Biosystems and Advanced Cell Diagnostics (ACD) - a Bio-Techne brand, proudly announce the availability of the Aperio RNA ISH ...
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for UK-based media - If approved by the FDA, avelumab, an investigational immunotherapy, could be the first treatment indicated for patients with metastatic Merkel cell carcinoma (MCC) - Avelumab has previously received FDA Breakthrough Therapy and Fast ...
Or Yehuda, Israel (ots/PRNewswire) - Transaction Provides Opportunity to Optimize the Significant Potential of the Cardioband[TM] Heart Valve Repair System Valtech Cardio, Ltd. (http://www.valtechcardio.com/), (Valtech), an innovator in the field of device development for mitral and tricuspid valve repair and replacement, today announced agreement to be acquired by Edwards Lifesciences Corporation (Edwards). The ...
Rheinfelden, Switzerland (ots/PRNewswire) - Tillotts Pharma AG (Switzerland) introduced a new advanced enteric coating for solid dosage forms at this year's annual meeting of the American Association of Pharmaceutical Scientists. The OPTICORE(TM) coating technology comprises two trigger systems and an accelerator to ...
Aachen, Germany / Pittsburgh, PA, USA (ots) - - The acquisition supports Grünenthal's commercial and R&D strategy to drive innovation in pain. - Thar Pharmaceutical's lead compound, T121, complements Grünenthal's existing development pipeline and the goal of delivering innovative and effective treatments to ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts (ots/PRNewswire) - Data reveals key findings on the tolerability of CUVITRU [Immune Globulin Subcutaneous (Human), 20% Solution] for patients, regardless of treatment infusion volume and rates Shire plc (LSE: SHP, NASDAQ: SHPG) will present additional data supporting the tolerability of ...
Bagsværd, Denmark (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Results from a study comparing the pharmacodynamics of Tresiba® (insulin degludec) with insulin glargine U300 in people with type 1 diabetes were presented ...
Paris (ots/PRNewswire) - - Toujeo® provides a flatter profile than insulin degludec with less within-day fluctuations - Sanofi (http://www.sanofi.com) presented today the full results of a pharmacokinetic / pharmacodynamic (PK/PD) study with Toujeo® (insulin glargine 300 Units/mL) and insulin degludec 100 Units/mL ...
Lugano, Switzerland and San Diego (ots/PRNewswire) - Data to be presented on December 3, 2016; Abstract now available online Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel ...
New Orleans (ots/PRNewswire) - This material is intended for global medial media only. For journalistic assessment and preparation before publication. Abstract #T-P-3178, oral session #T-OR-2088 US study identified multiple barriers to weight management for people living with obesity Divergent perceptions and attitudes about obesity may jeopardise obesity management ...
Harare, Zimbabwe (ots/PRNewswire) - Circ MedTech (http://www.prepex.com/) Ltd., manufacturer of PrePex[TM] - the world's only non-surgical male circumcision device - donated three Mobile Clinics to the Zimbabwe Ministry of Health and Child Care with the aim to support the scale-up of Male Circumcision programs, as part of Zimbabwe's HIV Prevention strategy. (Photo: ...